Figure 2. LSCM images of melanostatin delivery into excised human skin.
Representative melanostatin (MEL) treated confocal laser scanning microscopy (CLSM) images of viable epidermis and dermis at 1 and 24 hour(s) are shown without and with microneedle (MN) delivery enhancement. Mosaic images of the viable epidermis and dermis (top row and bottom row, respectively) are shown at at 1 and 24 hour(s) after melanstatin delivery with microneedle enhancement. Each mosiac is 5×5 mm2.